Tag: Biocon

Mumbai: Biocon expects a stronger second half of FY27, driven by four growth engines, its Ustekinumab and Aflibercept biosimilars in the US, the upcoming launch of Pertuzumab in Europe ...

Roche's Genentech has settled a US lawsuit against Indian biopharmaceutical company Biocon over its proposed biosimilar of Genentech's blockbuster breast-cancer drug Perjeta, Biocon said Wednesday.* Biocon said in a ...

New Delhi, Biocon Ltd on Tuesday said its arm Biocon Biologics has received marketing approval for its pegfilgrastim biosimilar from Japan's Ministry of Health, Labour and Welfare (MHLW).The pegfilgrastim ...

Mumbai: Biopharma major Biocon is going full throttle on adoption of artificial intelligence and scaling up investments to embed the latest generation data science and analytical tools deeply into ...

New Delhi: Biocon Ltd on Tuesday announced the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (biosimilar to Prolia) and Aukelso ...

Indian biopharmaceutical company Biocon said on Saturday it would fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary.Biocon said in a statement it will acquire the ...

Biocon Ltd is exploring the merger of biosimilars arm Biocon Biologics Ltd with itself, people aware of the development told ET. The potential deal is said to value the ...

Biopharmaceutical firm Biocon plans to invest $150 million in capital expenditure over the next couple of years, with $100 million earmarked for its biologics division and the remaining for ...

Biocon Biologics, the subsidiary of Biocon on Saturday has received the USFDA nod to launch the biosimilar version of Janssen's Stelara (Ustekinumab) used for the treatment of autoimmune disorders ...

New Delhi: Biocon Ltd on Monday announced the signing of a semi-exclusive distribution and supply agreement with Mexico-based Medix for the commercialisation of its drug Liraglutide (gSaxenda), used in ...